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Background: Silicon dioxide composites have been found to enhance the mechanical properties 
of scaffolds and to support growth of human adipose tissue-derived stem cells (hADSCs) both 
in vitro and in vivo. Silica (silicon dioxide alone) exists as differently sized particles when 
suspended in culture medium, but it is not clear whether particle size influences the beneficial 
effect of silicon dioxide on hADSCs. In this study, we examined the effect of different sized 
particles on growth and mitogen-activated protein kinase signaling in hADSCs.
Methods: Silica gel was prepared by a chemical reaction using hydrochloric acid and sodium 
silicate, washed, sterilized, and suspended in serum-free culture medium for 48 hours, and then 
sequentially filtered through a 0.22 μm filter (filtrate containing nanoparticles smaller than 
220 nm; silica NPs). hADSCs were incubated with silica NPs or 3 μm silica microparticles 
(MPs), examined by transmission electron microscopy, and assayed for cell proliferation, 
apoptosis, and mitogen-activated protein kinase signaling.
Results: Eighty-nine percent of the silica NPs were around 50–120 nm in size. When hADSCs 
were treated with the study particles, silica NPs were observed in endocytosed vacuoles in the 
cytosol of hADSCs, but silica MPs showed no cell entry. Silica NPs increased the proliferation 
of hADSCs, but silica MPs had no significant effect in this regard. Instead, silica MPs induced 
slight apoptosis. Silica NPs increased phosphorylation of extracellular signal-related kinase 
(ERK)1/2, while silica MPs increased phosphorylation of p38. Silica NPs had no effect on 
phosphorylation of Janus kinase or p38. Pretreatment with PD98059, a MEK inhibitor, prevented 
the ERK1/2 phosphorylation and proliferation induced by silica NPs.
Conclusion: Scaffolds containing silicon dioxide for tissue engineering may enhance cell 
growth through ERK1/2 activation only when NPs around 50–120 nm in size are included, and 
single component silica-derived NPs could be useful for bioscaffolds in stem cell therapy.
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Introduction
A number of bioceramic mixtures have been evaluated in terms of their ability to 
promote cellular attachment and induction of osteogenic differentiation. There have 
been many reports of enhanced cellular bioactivity using biosilicates (P
2
O
5
-Na
2
O-CaO-
SiO
2
),1 calcium-magnesium-silicate ceramics,2 calcium-silica ceramics,3 and bioactive 
glass (Ca-Sr-Na-Zn-Si).4 Mesoporous silica particles are also being used for controlled 
release scaffolds,5 and many bioceramics include a silica component.
Silica is a ceramic material that has been successfully used for regeneration of bone 
and cartilage. It exists naturally in small quantities in a water-soluble form, but is most 
often found in an insoluble form.6 Orthosilicic acid (Si[OH]
4
), a soluble form of silicon, 
does not affect the synthesis of type I collagen for bone tissue regeneration, whereas an 
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insoluble form, silica (SiO
2
), enhances the synthesis of type 
I collagen and alkaline phosphate.7 Silica-based ceramics 
are mechanically strong and suitable for bone regeneration.8 
Silicon nitride is resistant to bacterial infection during bone 
regeneration,9 and silicon increases the proliferation and 
osteogenic differentiation of osteoblast-like cells.10 In addi-
tion, silica-based bioglass ceramics and biosilicates enhance 
bone-like structure formation.1,2 A mixture of silicon and 
calcium,3,11 or mixtures with various other materials, includ-
ing zinc and magnesium,12 improve both gene expression and 
biological performance.
Adult mesenchymal stem cells can be isolated from 
various tissues, including bone marrow, umbilical cord 
blood, cord matrix, and adipose tissues. Recently, adipose 
tissue-derived stem cells (ADSCs) have been used in the tis-
sue engineering field owing to their abundance and ease of 
separation.13,14 ADSCs have been used for tissue regeneration 
to induce osteogenic differentiation in cell therapy. ADSCs 
combined with an hydroxyapatite bioceramic scaffold can 
construct vascularized tissue-engineered bone.15 ADSCs 
strongly induce osteogenic differentiation when applied to 
multiple-combination, such as electromagnetic field, ultra-
sound, and cyclic strain.16
The extracellular signal-related kinase (ERK)1/2 signal-
ing pathway is a mitogen-activated protein kinase (MAPK) 
pathway that transduces signals from receptors and endo-
cytosis at the cell surface.17,18 ERK1/2 signaling is involved 
in biopolymer-induced proliferation and differentiation of 
stem cells. The ERK1/2 and Wnt signaling pathways are also 
involved in biomaterial-induced osteogenic differentiation.19 
Signaling by Janus kinase (JNK), a member of the MAPK 
family, activates cell death from hypoxia/reoxygenation 
condition in cultured ADSCs.20,21 Apoptosis of ADSCs 
driven by miR10b and miR23b expression occurs via the 
p38 signaling pathway.22
Most studies have evaluated bioceramic materials 
containing multiple components with silica. No evidence 
regarding silica alone as a biomaterial component is avail-
able. Given that mixtures of ceramic compounds are used to 
construct bioscaffolds, interference in the components of the 
mixture may occur, and their effects on the cellular response 
could differ. It is necessary to evaluate cellular responses to 
single-component scaffolds. When chemically synthesized 
silica is suspended in culture medium, it contains differently 
sized particles. It is unclear whether particle size affects the 
effect of silica on human ADSCs (hADSCs). Therefore, in 
this study, we examined whether single-component silica 
containing different sized silica particles, ie, nanoparticles 
(NPs) or microparticles (MPs), has a differential effect on 
proliferation and MAPK signaling in hADSCs.
Materials and methods
cell preparation and culture
hADSCs were isolated and cultured as described previously.23 
Informed consent was obtained from patients in accordance 
with the requirements of the institutional review board at 
Seoul St Mary’s Hospital, Republic of Korea (KC11T-
NMS0095). Raw lipoaspirates from patients were washed 
thoroughly with sterile phosphate-buffered saline (Life Tech-
nologies, Carlsbad, CA, USA), minced, and then digested 
with 0.1% type I collagenase (Sigma-Aldrich, St Louis, MO, 
USA) in phosphate-buffered saline for 30 minutes at 37°C in 
a 5% CO
2
 atmosphere with gentle agitation. The collagenase 
was inactivated with an equal volume of culture medium 
containing 10% fetal bovine serum (Wisent Inc, St Bruno, 
QC, Canada). Cells were harvested by centrifugation at 
250× g for 5 minutes and filtered through 100 μm mesh to 
remove debris. The cells were plated onto conventional cul-
ture plates in Dulbecco’s modified Eagle’s medium (DMEM, 
Life Technologies) containing 10% fetal bovine serum and 
1% antibiotic/antimycotic (Life Technologies) at 37°C in 
a humidified atmosphere containing 5% CO
2
. The culture 
medium was changed every 3 days.
Preparation of medium containing 
different sized particles 
Silica gel was prepared via a chemical neutralization reaction 
by mixing hydrochloric acid with a solution of reagent grade 
sodium silicate (SiO
2
 26.5%, Na
2
O 10.6%, and H
2
O 62.9%, 
Sigma Aldrich; Figure 1A and B). Silica gel of 6 g synthe-
sized from the sodium silicate solution of 23 g according to 
the law of conservation of mass. After thorough washing 
with phosphate-buffered saline and sterilization, the gel was 
added to 100 mL of DMEM for 48 hours. The gel-containing 
medium was filtered through a 0.22 μm filter (Thermo, 
Waltham, MA, USA). Filtered DMEM have got silica 
NPs (silica NP medium). Silica MPs purchased from Ditto 
Technology (Anyang City, Korea) were suspended same 
concentration of silica NP medium in DMEM (silica MP 
medium). The particle concentration in each type of medium 
was measured using an inductively coupled plasma optical 
emission spectrometer (Varian 710-ES, Varian, Melbourne, 
Australia). The size of the silica NPs was determined by trans-
mission electron microscopy (JEM1010, JEOL Ltd, Tokyo, 
Japan). Basic fibroblast growth factor (Sigma-Aldrich) was 
used as a positive control.
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Total DNa assay
To evaluate cell proliferation and apoptosis, total DNA 
content was measured using the CyQUANT® cell prolifera-
tion assay kit (Life Technologies), according to the manu-
facturer’s protocol. Cells were cultured in a 96-well plate 
at 37°C in a 5% CO
2
 atmosphere for 1, 3, and 5 days at a 
density of 3,000 cells/well with DMEM (with 1% fetal bovine 
serum) containing silica NPs and MPs, and then washed with 
phosphate-buffered saline to remove nonadherent cells. Cells 
were mixed in lysis buffer for an hour and CyQUANT GR 
dye was mixed with lysis buffer in a 96-well plate, which 
was then incubated for 10 minutes. Fluorescent signals were 
detected with excitation at 480 nm and emission at 520 nm 
using a spectrofluorometer (Gemini, SpectroMAX, Sunny-
vale, CA, USA).
Annexin V analysis by flow cytometry
Cells were cultured in a 12-well plate at a density of 30,000 cells/
well for confluency. They were then treated with 1× phosphate-
buffered saline and transferred to a  fluorescence-activated cell 
sorting tube with phosphate-buffered saline at a concentration 
of 25,000 cells/mL and centrifuged at 1,000× g. The cells were 
stained with Annexin V and propidium iodide (BioBud Inc, 
Seoul, Korea) according to the manufacturer’s protocol. The 
cells were mixed with 500 μL of 1× binding buffer and incu-
bated with 1.25 μL of Annexin V in the dark for 15 minutes. 
After treatment, the cells were collected, mixed with 500 μL 
of 1× binding buffer and 10 μL of propidium iodide, and ana-
lyzed immediately by flow cytometry (BD FACSCalibur™, 
BD Biosciences, San Jose, CA, USA).
assay of DNa fragmentation  
by DaPI staining
Cells were cultured in a six-well plate at 37°C in a 5% CO
2
 
atmosphere for 3 days at a density of 70,000 cells/well. The 
medium was then replaced with DMEM containing silica NPs 
or MPs. Cultured cells with NPs or MPs were incubated for 
7 days at 37°C in a 5% CO
2
 atmosphere. Culture medium 
was removed and DAPI reagent (Vector Laboratories Inc, 
Burlingame, CA, USA) was added. The stained cells were 
A
B
SiO2∙Na2O∙nH2O + HCl
Water glass
(SiO2∙Na2O∙nH2O)
Hydrochloric acid
(HCI)
Mixing Washing with
DW and PBS
Filtering
(220 nm)
Silica NP
medium
Incubation in medium
at 37ºC for 48 hours
Si(OH)4 + NaCl + nH2O
Si(OH)4
OH
OH
Orthosilicic acid Silicon dioxide
NaCl and Si(OH)4
removed through
washing process
Si O OSiOHHO
(Evaporation: 2H2O)
Soluble Insoluble
SiO2 + 2H2O
Figure 1 Preparation of silica NPs.
Notes: (A) conversion of orthosilicic acid to silicon dioxide. (B) Manufacturing process for silica by neutralization reaction. The silica NP medium was prepared by 
incubating silica in culture medium for 48 hours and then by filtering through a 0.2 μm filter.
Abbreviations: DW, distilled water; PBs, phosphate-buffered saline; NPs, nanoparticles.
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observed using a  fluorescence microscope (Axiovert200, 
Carl Zeiss, Oberkochen, Germany).
Protein extraction and Western blotting
Cultured cells were washed twice with ice-cold phosphate-
buffered saline, and 100 μL of T-PER protein extraction 
reagent (Thermo Scientific, Rockford, IL, USA) was added 
to the culture dish. After scraping, the contents of the dish 
were transferred to a 1.5 mL tube and shaken at 4°C for a 
minute. The samples were centrifuged for 15 minutes at 
4°C and 11,000× g. The supernatant was transferred to a 
1.5 mL flash tube. Quantitative analysis was performed 
using the Bradford assay (Bio-Rad, Hercules, CA, USA). 
For Western blotting, equal amounts of protein (15 μg) were 
electrophoresed in 10% sodium dodecyl sulfate-acrylamide 
gels. The proteins were transferred from the gel to a 0.45 μm 
nitrocellulose transfer membrane (Whatman GmbH, Dassel, 
Germany) using an electrical transfer system. Nonspecific 
binding was blocked with 5% skim milk (BD Biosciences) 
in TBST buffer (5 mM Tris-HCl [pH 7.6], 136 mM NaCl, 
0.1% Tween 20) for an hour. The blots were then incubated 
with the appropriate primary antibody (dilution 1:1,000) for 
24 hours at 4°C, after which they were washed three times 
with 1× TBST. Next, the blots were incubated for 2 hours at 
room temperature with a secondary antibody (1:5,000). The 
blots were washed three times with 1× TBST and developed 
using electrochemiluminescence Western detection reagents 
(GE Healthcare, Little Chalfont, UK). Blots were analyzed 
using a luminescent image analysis instrument (Fuji Pho-
tofilm, Tokyo, Japan). We used the Multi Gauge program 
(version 3.0) for quantitative assays. The primary antibodies 
used were specific for ERK1/2 (Cell Signaling Technology 
Inc, Danvers, MA, USA), p-ERK1/2 (Cell Signaling), JNK 
(Cell Signaling), p-JNK (Cell Signaling), p38 (Cell Signal-
ing), p-p38 (Cell Signaling), and actin (Sigma-Aldrich). The 
secondary antibodies were anti-rabbit and anti-mouse immu-
noglobulin G-horseradish peroxidase conjugates (both from 
Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA). 
Treatment with PD98059
Cells were grown to 70% confluency, after which the medium 
was replaced with fetal bovine serum-free DMEM. After 
24 hours, the cells were treated with PD98059 (40 μM; 
Cell Signaling Technology Inc) for 30 minutes, followed 
by incubation for 10 minutes with DMEM containing silica 
NPs or MPs. The negative control group was not treated with 
silica-containing medium, and the positive control group was 
treated with basic fibroblast growth factor.
Results
evaluation of silica NPs and MPs
Silica (99.8% purity) was prepared as reported previously 
(Figure S1A) and was synthesized in a dose-dependent man-
ner form the ratio of sodium silicate reagent (Figure S1B). 
The silica was then incubated in serum-free DMEM at 37°C 
for 48 hours and filtered through 0.22 μm mesh to obtain the 
silica NP fraction (Figure 1A and B). When we examined 
each type of medium by transmission electron microscopy, 
89% of particles in the silica NP medium were around 
50–120 nm in size (Figure 2A). Figure S2A and B show 
the respective size distributions for the silica NPs and MPs. 
Silica MPs obtained commercially was suspended in DMEM 
(Figure 2B). Seventy-eight percent of the silica MPs was 
about 2–4 μm in size. When hADSCs were incubated with 
each type of silica particle-containing medium for 24 hours, 
treatment of silica MPs showed no visible particles inside the 
cells like untreated cells (Figure 2C and D), whereas silica 
NPs entered the cytosol of cells (Figure 2E and F; Figure 
S3A and B). Some silica NPs were observed in endocytosed 
vacuoles in the cytosol of hADSCs. We therefore concluded 
that only silica NPs entered the cytosol, and in part through 
endocytosis.
effect of silica NPs and MPs on 
proliferation and apoptosis
Since silica composites are known to promote proliferation 
of mesenchymal stem cells, we tested whether differentially 
sized particles containing a single component, ie, silica, affect 
proliferation of mesenchymal stem cells. After incubation 
with the particles for one, 3, and 5 days, hADSCs underwent 
quantification of their DNA content using the CyQUANT 
cell proliferation assay kit (Figure 3A). The same amount 
of silicon was used in each culture to compare the cellular 
activity of the particles. Silica NPs increased cell prolifera-
tion significantly, but silica MPs showed no stimulation of 
cell proliferation, even at day 5.
Next, we tested whether the particles have differential 
effects on apoptosis of hADSCs. Analysis of apoptotic cells 
by Annexin V staining confirmed that hADSCs exposed 
to silica MPs undergo apoptosis (6.49%) in a 1% serum 
medium, albeit at a low degree. In contrast, silica NPs had no 
effect on apoptosis (0.16%; Figure 3B). DNA fragmentation, 
detected by DAPI staining, was observed only in silica MP-
treated cells and not in silica NP-treated cells (Figure 3C). 
Thus, we concluded that silica NPs stimulated proliferation 
of ADSCs, whereas silica MPs induced apoptosis, albeit at 
a very low level.
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A
0.2 µm 4 µm
2 µm 1 µm
1 µm 0.5 µm
Nucleus
Cytosol
B
C D
E F
Figure 2 Transmission electron microscopy of different sized particles and observation of treated cells.
Notes: (A) NP and (B) MP media were observed by transmission electron microscopy. adipose tissue-derived stem cells were incubated in each type of medium for 24 
hours and then observed by transmission electron microscopy. representative images are shown for (C) untreated cells, (D) silica MP-treated cells, and (E, F) silica NP-
treated cells. Black arrows indicate particles and the triangle indicates a vesicle.
Abbreviations: NP, nanoparticle; MP, microparticle.
effects of silica NPs and MPs on MaPK 
signaling
We examined whether differently sized silica particles 
affected MAPK signaling. After ADSCs were exposed to 
silica NP or MP medium for 10 to 60 minutes, we mea-
sured the phosphorylation levels of ERK1/2, p38, and JNK 
(Figure 4A). As shown in Figure 4B, the silica NP medium 
markedly increased the phosphorylation of ERK1/2 after 
10 minutes, and phosphorylation decreased gradually there-
after. The silica NP medium did not significantly affect p38 
phosphorylation, but the silica MP medium showed increased 
levels of the phosphorylated form of p38 (Figure 4C). How-
ever, there was no change in phosphorylation of JNK in either 
the silica NP or MP medium (Figure S4B).
To confirm the involvement of the ERK signaling 
pathway, cells were pretreated with PD98059 before 
silica NP medium was added. PD98059 indeed abolished 
phosphorylation of ERK1/2 in both basic fibroblast growth 
factor-treated and silica NP-treated cells. PD98058 also 
blocked the hADSC proliferation induced by silica NPs 
(Figure 4D). We concluded that silica NPs activated ERK1/2, 
whereas silica MPs activated p38.
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Figure 3 Proliferation and apoptosis assays in aDscs treated with silica particles.
Notes: (A) Proliferation assay was performed by measuring DNa content. Total DNa (ng/μl) was increased in silica NPs with 1% FBs group compared with NP and MP 
media groups (*P,0.001). experiments were performed in at least triplicate. The data are representative of three independent experiments. (B) Induction of apoptosis in 
human aDscs treated with silica NP medium or silica MP medium was detected by annexin V assay. aDscs were treated with silica NPs or silica MPs for 6 and 72 hours 
after the cells were incubated in FBs-free medium for 24 hours. (C) DaPI staining of cells incubated in each type of medium for 24 hours. White arrows indicate DNa 
fragmentation in silica MPs.
Abbreviations: aDscs, adipose tissue-derived stem cells; DaPI, 4,6-diamidino-2-phenyllindile; FBs, fetal bovine serum; NPs, nanoparticles; MPs, microparticles; siNPs, 
silicon nanoparticles; SiMPs, silicon microparticles; PI, propidium iodide; FITC, fluorescein isothiocyanate.
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Figure 4 activation of mitogen-activated protein kinases by differently sized silica particles.
Notes: (A) Protein extracts from the cells incubated in each type of medium for 10, 20, 30 and 60 minutes after starving in FBs-free medium for 24 hours were 
immunoblotted. (B, C) Quantitative analysis of erK1/2 and p38 phosphorylation level by densitometric analysis. Three independent experiments were performed (*P,0.01, 
**P,0.001). (D) erK1/2 activation by silica NPs was evaluated by treatment with PD98059, a MeK-erK inhibitor. Protein was extracted from cells pretreated with PD98059 
for 30 minutes, followed by treatment with silica NPs for 10 minutes. Quantitative analysis of three independent experiments by densitometric analysis was performed. 
ERK1/2 phosphorylation by basic fibroblast growth factor and silica NPs was prevented by pretreatment with PD98059 (*P,0.01, **P,0.001). (E) a proliferation assay was 
performed by measuring DNa content in cells pretreated with PD98059 followed by treatment with silica NPs. Total DNa (ng/μl) was increased in the silica NPs with 1% 
FBs group, whereas the pretreated group showed reduced proliferation. experiments were performed in triplicate at least.
Abbreviations: ERK, extracellular signal-related kinase; JNK, Janus kinase; NPs, nanoparticles; MPs, microparticles; bFGF, basic fibroblast growth factor; 
p-, phosphorylated; MeK, mitogen-activated protein kinase kinase; FBs, fetal bovine serum.
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Discussion
Many studies have shown that silica-based scaffolds and 
silica-coated plates induce cell proliferation, attachment, 
and biocompatibility.24–27 In previous reports, silicon has 
been shown to be released into culture medium and to induce 
cell proliferation.28,29 Interestingly, we found that silica 
NPs (around 50–120 nm in size) have effects on MAPK 
signaling and cell proliferation that were different from 
those of silica MPs (around 2–4 μm in size). Consistent 
with our observations, ceramic NPs have been reported to 
stimulate cell growth to a greater extent than MPs.30 Protein 
adsorption is also enhanced on nanostructured silicon,31 and 
nano-features increase the formation and adhesive strength 
of fibroblast cells.32
Silica-based scaffolds33 and coated plates34 have hydro-
philic properties. When we examined the interaction of 
silica-NP or silica-MP with ADSCs, only silica NPs entered 
the cells and some were clustered in the vesicles, suggesting 
that silica NPs enter the cells in part through endocytosis. Of 
note, no particles were observed in the nucleus (Figure 2E 
and F). Additionally, Figure S3 shows endocytosis of silica-
NPs that have been entering into the cytosol of cell. This find-
ing indicates that silica NPs in vesicles and the cytosol may 
affect signaling pathways.17,18 In contrast, silica MPs were 
not transferred to the cytosol (Figure 2D), suggesting that 
their particle size might have impeded access. Interestingly, 
we found that silica NPs increased growth of hADSCs, 
whereas silica MPs induced apoptosis (Figure 3). Therefore, 
it is possible that endocytosis of silica NPs accelerates cell 
growth whereas cell membrane stress caused by silica MPs 
induces apoptosis.35
To further address the mechanism of action of these 
differentially sized particles, we examined the effects of 
silica NPs and MPs on the MAPK pathway (Figure 4A). 
Involvement of ERK1/2 signaling in cell growth has been 
reported previously.36 Exposure of cells to silica NP medium 
initially resulted in potent activation of ERK1/2 signaling, 
followed by a return to basal levels (Figure 4B). Although 
the results of this experiment cannot be directly introducing 
exocytosis but cell metabolism was circulated according to 
endocytosis and exocytosis.37 Silica NPs had no effect on 
phosphorylation of JNK (Figure S4B), which is involved in 
apoptosis and inflammation.38,39 The p38 signaling pathway 
is related to cell stress and apoptosis.36,39 Consistent with 
previous reports, the p38 signaling pathway was not affected 
significantly by silica NPs, whereas silica MPs increased p38 
phosphorylation levels (Figure 4C).
We confirmed the effect of silica NPs on ERK signaling 
by inhibiting MEK, an upregulator of ERK signaling. The 
proliferation-related MEK-ERK1/2 signaling pathway is 
suppressed by PD98059 via MEK signaling inhibition,40 
while phosphorylation of JNK and p38 signaling are 
unaffected.38 Our results showed that PD98059 dose-
dependently decreased phosphorylation of ERK in the 
silica NP medium (Figure S4A). Thus, the data indicate 
that PD98059 inhibits MEK-ERK1/2 signaling driven 
by silica NPs. Consistent with the proliferation effect of 
silica NPs, PD98059 also suppressed the proliferation of 
Silica NPs
Membrane
Stress
Silica MPs
Endocytosis
MEK
ERK
PD98059
Cytoplasm
Nucleus Survival, proliferation Necrosis, apoptosis
Figure 5 Proposed signaling pathways affected by silica NPs and silica MPs.
Abbreviations: NPs, nanoparticles; MPs, microparticles; erK, extracellular signal-related kinase; MeK, mitogen-activated protein kinase kinase.
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hADSCs stimulated by silica NPs (Figure 4E). Together, 
the results indicate that silica NPs induce cell proliferation 
by activating the ERK1/2 signaling pathway (Figure 5). 
Attenuation and stabilization of growth factor signaling 
by endocytic control has been shown.18 It is still unclear 
whether endocytosis of silica NPs affects activation of ERK. 
In future, we will evaluate the signaling pathways involved 
in the multidifferentiation potency of hADSCs containing 
silica-NP and MP products.
Conclusion
Our results confirm that silica NPs enter the cytosol through 
the cell membrane by endocytosis, and silica NPs have accel-
erated cell growth. These data suggest that a silica NP size 
in the range of 50–120 nm is more effective in promoting 
stem cell growth by stimulating the ERK signaling pathway 
and that silica MPs induce apoptosis. But, this result was 
uncertain, when silica MP induced phosphorylation of P38. 
We will identify to the relevance of silica MPs and apopto-
sis as a future study. Therefore, selection of silica particle 
size is important when producing a scaffold used in tissue 
engineering and cell therapy.
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silica nanoparticles activate erK signaling of adipose stem cells
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Figure S1 Analysis of purified silicon dioxide (silica).
Notes: (A) Purity (99.81%) of prepared silica gel was determined by X-ray fluorescence analysis. (B) standard curve indicates that the amount of silicon is proportional to 
the amount of sodium silicate that was reacted with hydrochloric acid. The amount of silicon was analyzed by an inductively coupled plasma method.
Figure S2 Particle distribution of silica NPs and silica MPs.
Notes: (A) silica NP distribution according to size, ie, ,50 nm (1.6%), 50–80 nm (21%), 80–120 nm (68%), and 120–150 nm (8.9%). (B) silica MP distribution according to 
size, ie, ,2 μm (5%), 2–4 μm (78%), and .4 μm (17%) (*P,0.01).
Abbreviations: NPs, nanoparticles; MPs, microparticles.
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Figure S3 Transmission electron microscopic images of cells treated with silica nanoparticles.
Notes: (A) and (B) show cell membrane that vesicles entered to cytosol by endocytosis and triangle arrow indicates endocytosis of nanoparticles.
B
1
NPs MPs
0.75
0.5
0.25
0
Control 10 20
Exposure time
30
Ex
pr
es
si
on
 o
f p
-J
N
K
A
p-ERK
ERK
Actin
Time (minutes)
Silica NPs
PD98059 (µM)
10
–
0
10
+
0
10
+
10
10
+
20
10
+
30
10
+
40
Figure S4 erK and JNK Phosphorylation of haDscs with silica NPs and MPs.
Notes: (A) Phosphorylation of erK induced by silica NPs is inhibited by PD98059 in a dose-dependent manner. (B) Quantitative analysis of JNK phosphorylation level 
of aDscs by densitometric analysis according to silica NPs and silica MPs. reproduced with permission from Kim KJ, Jeon YJ, lee Jh, et al. The effect of silicon Ion on 
Proliferation and Osteogenic Differentiation of human aDscs. Korea Tissue Engineering and Regenerative medicine. 2010;7(2):171–177.1
Abbreviations: NPs, nanoparticles; MPs, microparticles; erK, extracellular signal-related kinase; JNK, Jun amino-terminal kinases; PD98059, MeK-erK inhibitor.
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